A real-world study of BBIBP-CorV vaccine effectiveness in a Sri Lanka rural province
Individuals who have received two doses of the BBIBP-CorV vaccine are protected against hospitalisation, severe COVID-19 disease, and death. Duration of protection against hospitalisation, severe COVID-19, and fatal COVID-19 sustained at least 121 days, with no sign of waning during that time.
Authors
- Lanka Wijekoon (ORCID: https://orcid.org/0000-0002-9301-7834)
- D Xie
- Nuwan Wickramasinghe
- Prasanna Weerawansa (ORCID: https://orcid.org/0000-0001-8711-9204)
- Chamara Sarathchandra (ORCID: https://orcid.org/0000-0002-7175-258X)
- Yunkai Yang (ORCID: https://orcid.org/0000-0002-7034-5077)
- Thilina Rathnasekara (ORCID: https://orcid.org/0000-0001-5779-4890)
- Sisira Hemananda Siribaddana (ORCID: https://orcid.org/0000-0001-5821-2557)
- Hemal Senanayake (ORCID: https://orcid.org/0000-0001-5739-1979)
- Ranjan Ganegama
- X Liu
- Zhaofeng Li (ORCID: https://orcid.org/0000-0001-7571-1083)
- Yaowen Zhang (ORCID: https://orcid.org/0000-0002-2379-6174)
- Thejana Somathilake
- Rui Ma
- Shouyi Qin
- Yuntao Zhang (ORCID: https://orcid.org/0009-0006-9134-5582)
Institutions
- Rajarata University of Sri Lanka (LK)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37662
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78